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ABSTRACT 
Electroconvulsive treatment (ECT) has developed over 70 years to a modern, effective way of lifting 
depressive moods. Memory loss and visual acuity after electroconvulsive treatment is the only remaining 
relevant criticism of the treatment modality when considering the overall rate of remission from this 
treatment compared to all other treatment modalities. A depressive state impedes memory, and memory 
improves on several qualities of cognition after treatment. However, the comparison of a person’s memory 
ability from the months before depression started to the level after a course of ECT is never performed, for 
obvious reasons. Some infectious diseases are known to influence memory negatively through effects on 
the dopamine receptors. More specifically, former toxoplasmosis infection may be a factor. Preliminary 
data on titres of toxoplasma IgG may indicate a connection to the development of long-standing memory 
problems after ECT.  
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INTRODUCTION  
The question of memory loss after electroconvulsive treatment 
is unsettled and interferes with the scientific handling of severe 
depression. Lay concerns get a wide coverage in the media and 
in scientific journals [1]. However, thorough reviews of the 
literature and practice seem to not get the same coverage [2, 
3]. Memory loss ((λήθη)=lethe), named after the river in the 
underworld in Greek mythology, has as its counterpoint truth 
(λήθη) not lie, according to the Greek view. It has been 
previously hypothesised that meeting the truth may be a 
problem for the depressed after the often speedy recovery 
during ECT [4]. On the other hand, certain infections by 
protozoa and bacteria may also have an impact on central 
nervous function, even long after the index infection has 
subsided [5].  
Lafferty discussed the cultural influence of Toxoplasma gondii 
infection on behaviour and stated: “The latent prevalence of a 
long-lived and common brain parasite, Toxoplasma gondii, 
explains a statistically significant portion of the variance in 
aggregate neuroticism among populations, as well as in the 
'neurotic' cultural dimensions of sex roles. A link between 
culture and T. gondii hypothetically results from a behavioural 
manipulation that the parasite uses to increase its transmission 
to the next host in the life cycle: a cat. While latent 
toxoplasmosis is usually benign, the parasite's subtle effect on 
an individual personality appears to alter the aggregate 
personality at the population level. Drivers of the geographical 
variation in the prevalence of this parasite include the effects of 
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climate on the persistence of infectious stages in soil, the 
cultural practices of food preparation and cats as pets. Some 
variation in culture, therefore, may ultimately be related to 
how climate affects the distribution of T. gondii, though the 
results only explain a fraction of the variation in two of the four 
cultural dimensions, suggesting that if T. gondii does influence 
human culture, it is only one among many factors” [6].  
In a Russian study from 2001, Lobzin et al. asserted that 
patients with chronic toxoplasmosis had “marked disorders in 
higher nervous activity and psychomotor system” [7]. They 
found many cases among these patients with mistakes in 
attention tests, in head calculating and with delayed memory at 
a degree impeding functioning, in occupational tasks as 
technical operators. This is also corroborated in a Polish case 
report showing memory and language impairment after 
toxoplasmosis infection [5]. The patient had mild cognitive 
decline with apraxia and difficulties with attention even several 
months after the infection.  
In his millennial article “Memory loss after electroconvulsive 
treatment during its 70 years of practice”, Max Fink stated that, 
after the period with unmodified ECT, when fractures and panic 
were the great obstacles to accepting ECT, memory changes 
took their place [8]. The use of general anaesthesia and muscle 
relaxants made the procedure calm and more acceptable to 
patients and staff alike. The objections to the treatment from 
patients and advocates of the anti-psychiatry movement have 
been rooted in the old way of performing the procedure [1].  
Individual patients do feel uncomfortable with the, albeit short, 
procedure of anaesthesia, and some are frightened that they 
would not wake up after the session.  
A multitude of psychometric tests exist that were constructed 
to tap memory changes in patients [9]. The Sackeims group in 
New York used the following tests in patients undergoing ECT: 
the Cognitive Failures Questionnaire (CFQ), the Squire Memory 
Complaint Questionnaire (SMCQ) and the Global Self-
Evaluation of Memory (GSE-My). They appear to give disparate 
results, as shown by Berman and also Brakemeier [10].  
Fraser et al. studied the effect of ECT on autobiographical 
memory from 15 suitable studies [11]. She found that 
autobiographical memory impairment occurs as a result of ECT, 
but the memory loss was short term (<6 months) with objective 
measures, whereas the amnesia was judged more long term 
with subjective accounts. Fraser recommended further studies 
that would focus on the separate impact of the depression 
itself on memory. King et al. [12] performed this kind of 
research. Autobiographical memory is related to the depressive 
disorder itself and to other factors, such as comorbidity, 
trauma, age, ruminative state, culture and executive function, 
and is also related to ECT. The impact of each factor in patients 
is unknown, but is clearly present. The testing of 
autobiographical memory should be aimed at differentiating 
episodic from semantic memory and time from emotion.  
In another study, Meeter et al suggested “it is possible that 
before ECT, patients could not recall news events due to 
depression. After ECT, the recall of some memories was 
improved, but other memories were impacted by ECT and 
could thus not be recalled or recognised” [13]. Recognition 
tests of remote memory have been employed in many previous 
studies. After employing further tests, Meeter et al. concluded 
by stating that ECT, as now practised, does not cause significant 
lasting retrograde amnesia.  
A difference between aspects of memory deficits has been 
observed when comparing patients referred for ECT and not 
referred [14]. The ECT patients showed more executive 
function deficit, but less visuospatial memory reduction than 
equally severely depressive patients not referred for ECT.  
The measurement of memory loss to prove any connection to 
ECT is phenomenologically and methodologically difficult [15-
18]. There is seldom access to measurements of memory 
function in patients from the time before they developed the 
depression. However, it may be possible to access information 
on the level of parasites and protozoa in the society [6, 19]. 
Measuring memory shortly before an ECT series starts will 
always show a degree of memory impairment as the depression 
itself reduces memory acuity.  
The existence of a common biological factor that might 
fluctuate between cultures would complicate the evaluation of 
memory loss after ECT. Tests have been initiated to evaluate 
this connection regarding former toxoplasmosis infection in ECT 
patients.  
 
HYPOTHESES 
The memory loss seen in some patients undergoing 
electroconvulsive treatment (ECT) is not explained by the 
treatment alone. A growing body of evidence suggests that the 
parasite-entrained dysregulation of dopamine metabolism may 
play a role. This dysregulation may lead to memory impairment 
in patients not otherwise prone to memory problems.  
Laboratory data was collected on toxoplasmosis infection 
status for seven patients who underwent a series of 
electroconvulsive treatments. None had an earlier recognised 
cognitive deficit or memory loss. The indication for ECT was 
either a unipolar or a bipolar depressive episode. Memory loss 
was defined as forgetting places, names and appointments 
more than two months after the end of the ECT series. The 
patients were observed during ECT sessions and at least six 
months after the end of the ECT series.  
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RESULTS 
Three of the seven patients investigated suffered from memory 
loss more than two months after the end of the ECT series (see 
table 1). Two of the three had an elevated titre of 
toxoplasmosis IgG, but none of the four patients without 
memory loss had an elevated value of toxoplasmosis IgG. All 
patients were of a similar age, ranging from 46 to 63 years, and 
included three men and four women.  
 
Table 1. Toxoplasmosis IgG and IgM titre in patients after ECT and 
development of post treatment cognitive deficits 
 
Case 
no.  
Age Sex Toxoplasma 
IgG 
Toxoplasma 
IgM 
Cognitive 
deficit as 
post ECT 
memory 
loss 
1 54 F 0.0 IU/ml Negative No 
2 46 M 0.3 IU/ml Positive, low 
titre 
No 
3 53 F 171.1 IU/ml Negative Yes 
4 40 F 0.1 IU/ml Negative No 
5 63 M 0.2 IU/ml Negative No 
6 49 M 0.2 IU/ml Negative Yes 
7 47 F 13.9 IU/ml Negative Yes 
 
DISCUSSION 
The observations of this preliminary study of toxoplasmosis 
titre in patients undergoing ECT may give some support to the 
findings of changes in mental capacity and memory shown by 
others [20]. The mechanism may be through the effect of 
Toxoplasma gondii on mammalian dopaminergic cells. The K+-
induced release of dopamine increases several-fold with a 
direct correlation between the number of infected cells and the 
quantity of dopamine released. When a toxoplasma infection 
deteriorates it may lead to encephalitis causing gradual 
forgetfulness and other mental and infection-related symptoms 
as reported in a review and case study by Habek et al. [21]. The 
case presented with a two-month history of cognitive decline. 
The most prominent deficit was in short-term verbal and visual 
memory and recognition, which was very similar to the 
symptoms presented by case 6. The IgG titres in the nine cases 
described by Habek et al. were all much higher, as expected. 
The degree of behaviour changes after toxoplasma infection 
appear to be parasite strain-dependent [22]. 
There are two different manipulations possible during ECT to 
reduce the risk of memory problems after ECT [23, 24]:  
•Ultra-brief stimulation at 0.25 or 0.30 msec 
•Right unilateral stimulation [25] 
These changes may be applied in a well-equipped ECT suite. 
Thus, the clinicians would have methods available to minimise 
the risk of cognitive side-effects. The anti-depressive effect of 
ECT using these alternative manipulations is, however, reduced 
according to some researchers in the field [15, 26, 27]. 
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